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The female protective effect in autism spectrum
disorder is not mediated by a single genetic locus
Jake Gockley1, A Jeremy Willsey1,2, Shan Dong1,3, Joseph D Dougherty4,5, John N Constantino4*
and Stephan J Sanders1,2*
Abstract
Background: A 4:1 male to female sex bias has consistently been observed in autism spectrum disorder (ASD).
Epidemiological and genetic studies suggest a female protective effect (FPE) may account for part of this bias;
however, the mechanism of such protection is unknown. Quantitative assessment of ASD symptoms using the
Social Responsiveness Scale (SRS) shows a bimodal distribution unique to females in multiplex families. This leads to
the hypothesis that a single, common genetic locus on chromosome X might mediate the FPE and produce the
ASD sex bias. Such a locus would represent a major therapeutic target and is likely to have been missed by
conventional genome-wide association study (GWAS) analysis.
Methods: To explore this possibility, we performed an association study in affected versus unaffected females,
considering three tiers of single nucleotide polymorphisms (SNPs) as follows: 1) regions of chromosome X that
escape X-inactivation, 2) all of chromosome X, and 3) genome-wide.
Results: No evidence of a SNP meeting the criteria for a single FPE locus was observed, despite the analysis being
well powered to detect this effect.
Conclusions: The results do not support the hypothesis that the FPE is mediated by a single genetic locus;
however, this does not exclude the possibility of multiple genetic loci playing a role in the FPE.
Keywords: Autism spectrum disorder, Sex bias, Female protective effect, GWAS
Background
Autism spectrum disorder (ASD) is characterized by im-
pairments in reciprocal social behavior, deficits in lan-
guage development, and repetitive behavior or restricted
interests. ASD is highly heritable [1], and progress has
been made in identifying specific genetic loci [2-8] and
the pathological mechanisms they target [9-11]. A dra-
matic sex bias is consistently observed in ASD [12], with
males affected more frequently than females. A 4:1 sex
bias is frequently cited, with estimates ranging from 2.8:1
to 6.4:1 [13-16]. Several recent publications [2,17-19] have
raised the possibility that this sex bias may be the con-
sequence of a female protective effect (FPE) reducing the
incidence in females.
The presence of a biological mechanism that reduces
the incidence of ASD in a risk-exposed population raises
the possibility of artificially inducing this protection as a
therapeutic or preventative measure for ASD. Hence, we
sought to investigate the molecular nature of the FPE.
While the FPE is clearly discordant between sexes, other
general sexual dimorphisms could confound discovery
of FPE-specific mechanisms. One approach is to try to
identify a subset of females in whom the FPE is absent,
for example, females with ASD.
Epidemiological evidence suggests that a substantial
portion of ASD risk is mediated by genetic risk factors
acting in an additive manner [1]. Families with multiple
children affected with ASD (multiplex) would be ex-
pected to have a higher burden of these genetic risk fac-
tors [20], so that the majority of their children would be
exposed to high ASD risk. Under this model, we would
expect ASD risk to be normally distributed in these chil-
dren but with a mean risk closer to the ASD diagnostic
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threshold than in the general population. In females, the
FPE results in a higher diagnostic threshold relative to
the population mean than in males, leading to a lower
female ASD incidence.
The Social Responsiveness Scale (SRS) is a quantitative
measure of ASD behaviors in affected and unaffected
individuals [21]. Treating the SRS as a proxy for the
underlying ASD risk, we would expect the SRS to be
normally distributed in the children of multiplex fam-
ilies, with a higher diagnostic threshold relative to the
population mean in females than in males. The observed
distribution in males from multiplex families (Figure 1A)
approximates this expectation (Figure 1C); however, fe-
males in multiplex families show a bimodal distribution
(Figure 1B) that differs from expectation (Figure 1D).
This bimodal distribution has been reported in ASD
cohorts from the Autism Genetic Resource Exchange
(AGRE) and the Interactive Autism Network (IAN)
[22,23]. There is a substantial difference of about 90
SRS points (4.5 standard deviations) between the two
peaks of the bimodal distribution in Figure 1B, suggest-
ing distinct subsets within the female cohort. In con-
trast, female SRS scores follow a unimodal distribution
in the general population with a mean score 3 points
(0.17 standard deviations) lower than for general popu-
lation males [24-26].
We considered whether this bimodal distribution could
reflect the categorical presence (low score) or absence
(high score) of a protective effect in females. If the FPE
was, itself, mediated by multiple protective factors, we
would still expect a normal distribution of SRS scores
(Figure 1E) with the mean shifted towards lower SRS
scores compared with males (Figure 1C,D). As the num-
ber of protective factors decreases, distinct distributions
would be expected based on the presence or absence of
the factors (Figure 1F) with a single protective factor
mediating the FPE leading to a bimodal distribution
(Figure 1G), as observed (Figure 1B). This leads to
the hypothesis that a single common genetic variant is
responsible for the FPE (Additional file 1: Figure S1).
To estimate whether a genome-wide association study
(GWAS) would detect such a protective factor, we per-
formed a power analysis. We expect the protective factor
to be enriched in female controls compared with female
cases, but to have no effect in male subjects, therefore
the presence of males adds ‘noise’ to a GWAS analysis
(Figure 2A). Under ‘ideal’ conditions, that is, that the 4:1
sex bias was solely the consequence of the FPE and that
the FPE was sufficient to prevent an ASD diagnosis, we
found that the largest GWAS to date (2,678 cases and
2,678 pseudocontrols [27]) would have 100% power to
detect such a protective allele. However, an assumption
of ideal conditions is unlikely to be accurate. Therefore,
we estimated the power if the FPE was only responsible
for 50% of the observed 4:1 sex bias as a means to model
deviation from ideal conditions (Figure 2B). The power
was reduced to 30% (Additional file 1: Supplementary
Methods and Figures 2B and Additional file 1: Figure S2).
We then repeated this power estimate for a GWAS
performed only on the females, who represented 16%
(5.25:1) of the cases [27], and found that the power
would increase from 30% to 100% (Figure 2B). In fact,
by varying the cohort size, we found that a female sub-
ject GWAS dramatically increased the power across a
wide range of conditions (Additional file 1: Figure S2).
We therefore concluded 1) that the GWAS conducted
so far would probably have missed a single locus FPE
and 2) that a female-only GWAS would be very well
powered to find such an effect across a wide range of
assumptions.
Based on these results, we performed a GWAS on the
AGRE dataset, comparing 208 affected females with 151
unrelated unaffected females. To maximize our power,
we considered single nucleotide polymorphisms (SNPs)
in three tiers as follows: 1) SNPs unique to chromosome
X that escape X-inactivation (Figure 3 and Additional
file 2: Table S4), since the increased dosage in females
provides a simple mechanism for female-specific protec-
tion; 2) All SNPs on chromosome X; and 3) All SNPs
across the whole genome. We used 207 affected females
and 676 unrelated unaffected females from the Simons
Simplex Collection (SSC) as a replication set. The SSC
was not used for discovery since affected status is less
likely to be determined by FPE absence, due to the lower
contribution of inherited risk [27] and higher contribu-
tion of de novo risk [5-7,18,19] in simplex families.
While the presence of a single locus mediating the
FPE may seem unlikely, the potential therapeutic impli-
cations of such a finding are so great that it was import-
ant to fully explore this possibility. To our knowledge,
no previous molecular genetic study of autism has re-
ported the results of such an analysis.
Methods
Subjects and genotyping
Genotyping data were collated from two independent
large cohorts of ASD families: 1,976 families from the
AGRE [28] and 2,733 families from the SSC [13].
The AGRE data were generated on one of the three
Illumina BeadArrays (Illumina, Inc., San Diego, CA,
USA): 550v1 (421 families), 550v3 (1,277 families), and
Omni 1M (278 families). Analysis was restricted to the
329,483 SNPs shared between all three arrays. The
SSC data were generated on one of the three Illumina
BeadArrays: 1Mv1 (421 families), 1Mv3 Duo (1,277
families), and Omni 2.5M (1,035 families). Analysis
was restricted to the 493,924 SNPs shared between all
three arrays.
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Figure 1 (See legend on next page.)
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Ancestry and data cleaning
Data were restricted to families of European ancestry, and
standard GWAS data cleaning were performed. European
ancestry was determined using EIGENSTRAT [29] and the
four core HapMap populations [30] (Additional file 1: Figure
S3). The resulting genomic inflation for European samples
was 1.03 (Additional file 1: Figure S3). SNP data were
cleaned using PLINK [31], specifically we only included
SNPs with minor allele frequency ≥0.03 (Additional file 1:
Supplementary Methods), genotype rate of ≥0.95 per sample
(minimum observed genotyping rate was 0.991), genotype
missingness per SNP ≤0.1, and Hardy-Weinberg equilibrium
<0.0001.
After data cleaning, there were 943 families and
317,574 SNPs for AGRE and 2,166 families and 440,778
SNPs for SSC.
Identifying unrelated females
Of the 943 remaining AGRE families, only 510 con-
tained at least one female with genotyping data. Where a
family had multiple females, only one was selected, with
a preference for unaffected females, since these are less
frequent in the AGRE sample. From these, 151 unaffec-
ted females and 208 affected females (defined as ‘autism’
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Figure 2 GWAS power estimate for a single factor mediating the FPE. (A) In females exposed to high ASD risk, the protective factor will
be enriched in unaffected individuals (green) and largely absent in cases (purple). We estimate a distinct difference in the frequency of the
protective allele in these two cohorts (Additional file 1: Supplementary Methods) for an analysis based only on females (red line). Conversely, the
protective allele has no effect in males and will be observed at an equal frequency in male cases and controls. Including males in a GWAS analysis will
therefore add noise (blue line, representing the observed 5.25:1 ratio of males to females in Anney et al. [27]) resulting in a reduction in power. (B) An
estimate of GWAS power to detect a single FPE allele in females only (red) and females and males (blue) under a model where protection contributes
50% of the observed 5.25:1 sex bias. The vertical lines represent the sample size in this study (red) and the Anney et al. [27] GWAS study (blue).
(See figure on previous page.)
Figure 1 Expected and observed Social Responsiveness Scale (SRS) scores in multiplex AGRE families. Children in multiplex families are
assumed to have inherited a high degree of ASD risk. Under a threshold model, a quantitative measure of ASD severity, such as the SRS, would
be expected to follow a normal distribution with unaffected individuals at the lower end. (A) The observed SRS scores for 927 male children
(95 unaffected in blue, 832 affected in red) with each bar showing the sum of the number of unaffected and affected males. The black line
shows the kernel density of the data, which approximates a normal distribution. (B) The corresponding plot is shown for 394 female children
(151 unaffected, 243 affected). The SRS scores produce a bimodal distribution, as noted previously [22,23]. (C) To assess the expected distribution
under quantitative trait model, we estimated the mean and standard deviation of the male observed data ‘A’ and used these characteristics to
simulate a normal distribution for the same number of individuals. The scores were sorted, and a threshold for affected status was chosen to give
the same number of affected and unaffected males as in ‘A’. Each bar shows the sum of the number of unaffected and affected simulated males,
while the black line shows the kernel density. (D) The expected distribution under quantitative trait model is shown using the same method as in
‘C’ but for 394 females based on the female data in ‘B’. The expected distribution differs markedly from the observed in females, but not in males.
(E) If multiple factors contribute to the presence of the FPE, then their combined effect is likely to produce a unimodal distribution. (F) As the
number of factors contributing to the presence of the FPE decreases, the unimodal distribution in ‘E’ develops distinct distributions based on the
number of factors present. (G) If only one factor contributes, then a bimodal distribution should be observed. (H) Finally, if there are no factors
and the FPE is universally present in females, a unimodal distribution will arise based on the distribution of risk rather than protection.
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analysis. Identity by descent demonstrated that these
samples were all unrelated (Additional file 1: Figure S4).
A similar approach was applied to the 2,166 remaining
SSC families, of which 883 had at least one female. In
families with multiple females, only one was selected, with
a preference for affected females, since these are less
frequent in the SSC sample. The analysis was therefore
performed on 207 affected females and 676 unaffected
females. A complete list of the samples included in the
analysis can be found in Additional file 3.
Figure 3 Identification of chromosome X SNPs that escape X-inactivation for tier 1 analysis. This Circos plot shows the length of
chromosome X proceeding clockwise with position 0 on the short arm at twelve o’clock. Adjacent to the chromosome position, the innermost
ring indicates chromosome banding by the depth of shading; two opposing black arrows indicate the centromere. Regions of chromosome Y
homology are shown in purple in the middle ring; SNPs in these regions were excluded from the tier 1 analysis leaving the SNPs unique to
chromosome X indicated in green. The outermost ring shows SNP density based on the genotyping array (see ‘Methods’ section) by the height
of the bars. Regions that are inactivated on one copy of chromosome X are shown in gray [32] and SNPs in these regions were excluded from
the tier 1 analysis, leaving only SNPs that escape X-inactivation, shown in red (Additional file 2: Table S4). Of the 6,955 SNPs on chromosome X,
451 (6.5%) were included in the tier 1 analysis.
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Determining SNPs of interest
For the first tier of analysis, SNPs on chromosome X
were selected if they lacked homology to chromosome Y
and escaped X-inactivation (Figure 3 and Additional file 2:
Table S4) [32]. These regions represent 14% of chromo-
some X (21.8 Mbp). This left 451 SNPs for analysis in the
AGRE data and 720 SNPs in the SSC data. For the second
tier analysis, all of chromosome X was considered with
6,955 SNPs in AGRE and 10,269 SNPs in SSC. Finally, for
the third tier of analysis, all SNPs that remained after
cleaning were included with 317,574 SNPs in AGRE and
440,778 SNPs in SSC.
Association testing
Association tests were performed using PLINK [31]
under a dominant model. All P values were corrected
for multiple comparisons, using Bonferroni correction
based on the number of SNPs analyzed in each tier. The
cluster plots of all SNPs highlighted by the analysis are
shown in Additional file 1: Figures S14 to S17.
Power calculation
Power was estimated using G*Power 3.1 [33], based on
the Fisher exact test. Hypothesized allele frequencies in
cases and controls were derived from the 4:1 sex bias
(see Additional file 1: Supplementary Methods). An alpha
of 0.05 after Bonferroni correction (based on the number
of SNPs analyzed) was used.
Results
Targeted association study: tier 1 SNPs
To test the hypothesis that the FPE is mediated by a com-
mon variant at a single locus, we performed an association
test comparing 208 affected females against 151 unre-
lated unaffected females. Since the FPE is unique to fe-
males, we reasoned that the region of the genome that
has the greatest potential for sexual dimorphism would
be the most likely location for such a locus, and there-
fore, the first tier of our analysis was performed on 451
SNPs that are unique to chromosome X and that es-
cape X-inactivation (Figure 3 and Additional file 3:
Table S4). No SNPs were significant after correcting for
the 451 comparisons (Figure 4A). Of the top five SNPs
(Table 1), only two had a dominant risk allele that was
observed more frequently in the affected females (odds
ratio >1) and none had allele frequencies close to the
prediction in both the affected and unaffected groups
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Figure 4 Manhattan plots of association study results. Results of association studies comparing 208 affected females and 151 unaffected females
from AGRE. To maximize the ability to identify a candidate variant for the FPE the association test was performed on three tiers of SNPs, based on the
a priori probability of mediating the FPE. (A) Tier 1: 451 SNPs unique to chromosome X that escape X-inactivation. No SNPs are significant after multiple
comparisons (horizontal red line). The top five SNPs (red) are labeled (Table 1). (B) Tier 2: all 6,955 SNPs on chromosome X. No SNPs are significant after
multiple comparisons (horizontal red line). The top five SNPs (red) are labeled (Table 2). (C) Tier 3: all 317,574 SNPs across the genome. No SNPs are
significant after multiple comparisons (horizontal red line). The top five SNPs (red) are labeled (Table 3).
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of these five SNPs was represented on the microarrays
used for the SSC replication cohort (207 affected fe-
males, 676 unaffected females); despite this SNP reach-
ing nominal significance, the dominant risk allele was
more frequent in the affected group, that is, the
opposite direction of effect observed in the discovery
sample. Given the targeted nature of this analysis, the
estimated power to discover a single locus meeting our
hypothesis was 100% even with modest enrichment of
unprotected females in the affected group (Additional
file 1: Figure S1).
Targeted association study: tier 2 SNPs
Since no clear candidates were observed in the tier 1
SNPs, we expanded the analysis to the whole of chromo-
some X to account for the possibility that our knowledge
of regions escaping X-inactivation may not be complete.
As with the tier 1 analysis, no SNPs showed significant
association after correcting for the 6,955 comparisons
(Figure 4B). Considering the top SNPs (Table 2), all five
showed a direction of effect that was consistent with
expectation, but with a lower odds ratio (see Additional
file 1: Supplemental Methods). None of these SNPs were
nominally significant in the SSC replication cohort. Of
note, none of the top five SNPs from the tier 1 analysis
were in the top five for the tier 2 analysis, despite all 451
tier 1 SNPs being included in this analysis. We estimated
our power to detect the hypothesized single FPE locus
to still be 100% for tier 2.
Genome-wide association study: tier 3 SNPs
Next, we considered the possibility that the protective
allele was not on chromosome X, (for example, an auto-
somal gene that was only expressed in the presence of
high estrogen levels). We therefore repeated the analysis
for all 317,574 SNPs in the AGRE group. Again, there
was no association after correction for multiple compari-
sons (Figure 4C), and none of the top five SNPs were
nominally significant in the replication group (Table 3).
Of note, none of the top five SNPs were on chromosome
X. Even with the larger number of SNPs, we estimated
our power to detect the hypothesized single FPE locus
to be 100% (Additional file 1: Figure S2).
Exploratory association analyses
Finally, we considered the possibility that our inability to
detect the hypothesized single FPE locus was due to in-
accurate differentiation of females with, and without, the
FPE. For instance, a female may be unaffected due to the
absence of risk factors despite absent FPE. We therefore
tried defining cases and controls by their SRS score ra-
ther than by categorical ASD diagnoses. No SNPs were
significant after multiple comparisons (Additional file 1:
Figures S5 to S8 and Additional file 1: Table S5). We
also considered whether extremes of the affected and
unaffected SRS distributions might be enriched for fe-
males in whom the FPE was present or absent (Additional
file 1: Figure S11). Again, no SNPs were significant after
multiple comparisons (Additional file 1: Table S5). In
addition, we performed all of the reported analyses under
Table 1 Top five SNPs from tier 1 analysis: unique to chromosome X in regions that escape X-inactivation


















Predicted . 97.0 <24.3 >88 ≤1×10−8 ≤0.05 97.0 <24.3 >88 ≤1×10−8
rs5913021 G/A 71.5 57.3 1.25 0.005 1.0 . . . .
rs5913336 A/G 49.0 63.6 0.77 0.006 1.0 69.6 60.9 1.14 0.007
rs5912329 A/G 71.4 58.2 1.23 0.01 1.0 . . . .
rs1395790 G/A 2.4 7.9 0.30 0.01 1.0 . . . .
rs6624177 A/G 60.0 72.2 0.83 0.02 1.0 . . . .
Table 2 Top five SNPs from tier 2 analysis: all chromosome X SNPs


















Predicted . 97.0 <24.3 >88 ≤1×10−8 ≤0.05 97.0 <24.3 >88 ≤1×10−8
rs2429799 A/G 21.2 7.3 2.90 0.0003 1.0 . . . .
rs5932245 A/G 97.1 87.4 1.11 0.0004 1.0 54.1 55.0 0.98 0.9645
rs878252 G/A 31.7 15.9 2.00 0.0006 1.0 29.0 25.6 1.13 0.1699
rs5928065 G/A 94.7 84.1 1.13 0.0008 1.0 88.4 93.3 0.95 0.5674
rs7063248 G/A 73.4 57.6 1.27 0.0017 1.0 97.1 96.6 1.01 0.1885
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an additive model; no genome-wide significant SNPs were
identified (Additional file 1: Figure S9 and S10, Additional
file 1: Table S6 and S7).
Discussion
The observation of a bimodal SRS distribution in fe-
males, but not males, from multiplex families raised the
possibility of a single genetic locus mediating a female
protective effect and resulting in a 4:1 sex bias in ASD.
Given the potential of such a locus as a therapeutic tar-
get, and the high likelihood that such a locus would be
missed by a GWAS with mixed sexes, we performed
an association study in females only, which was well
powered to detect such an effect.
We considered three tiers of SNPs based on the a
priori probability that genomic regions might harbor a
single locus for FPE. The first tier considered only SNPs
unique to chromosome X that escaped X-inactivation,
the second tier considered all SNPs on chromosome X,
and the third tier was a full genome-wide association
study. No SNPs reached significance after correcting for
multiple comparisons in any of the three tiers (Figure 4);
furthermore, there was no evidence of replication in
the SSC cohort, nor of a SNP in one tier being present
in the top five SNPs of the next tier. This result was
unchanged by an additive model (Additional file 1:
Figure S9 and S10), defining case/control status using
the SRS score (Additional file 1: Figures S11, Additional
file 1: Table S5), or considering the extremes of the SRS
distribution (Additional file 1: Table S5).
The female-only GWAS achieved considerably higher
power than a GWAS with both sexes and was extremely
well powered to detect a single locus for the FPE even
with marked deviation from the expected allele fre-
quency (Additional file 1: Figure S2). We therefore con-
clude that the FPE is unlikely to be mediated by a
single genetic locus. This negative result does not re-
duce the likelihood of a female protective effect being
responsible for the sex bias observed in ASD, nor does
it reduce the likelihood of this protection being medi-
ated by a polygenic effect.
There are several explanations for this negative result.
First, there may be little variance in the FPE between
females. For example, if the FPE was mediated by en-
dogenous estrogen levels above a certain threshold, and
all females exceeded this threshold, then the FPE would
be constant without genetic or environmental risk factors
having an effect. Alternatively, the FPE may vary between
females, but this variance is determined by multiple gen-
etic and/or environmental factors, for example, if the ex-
tent of FPE was dependent on the degree of endogenous
estrogen exposure. Finally, it is possible that a single envir-
onmental factor (for example, exogenous estrogen expos-
ure) determines the presence of the FPE, though such a
factor would need to act in the majority of females, but
not act in the majority of males.
The first explanation (FPE in all females) would not
lead to the bimodal SRS distribution that prompted this
study (Figure 1H), while the second (multifactorial FPE)
could only produce a bimodal distribution if the major-
ity of risk factors targeted a common biological pathway
or neurological process (Figure 1F). It is hard to recon-
cile the third explanation (a single environmental effect)
with the consistent sex bias observed across so many
studies.
This leads us to consider alternative explanations
for the bimodal distribution. We first considered ‘non-
biological’ biases in the manner of data collection.
One possibility is ascertainment bias, that is, that
unaffected males are rare in multiplex families, while
unaffected females are detected comparatively fre-
quently. Simulation of multiplex families shows that
ascertainment bias and a 4:1 sex bias can induce a
bimodal distribution in ASD liability that is more
pronounced in females (Additional file 1: Figure S12A
and S12B). However, we do not think this is the
complete explanation of the SRS distribution since the ob-
served data differs from the expectation of this model in
two important respects:
First, the lower distribution in females (Additional file 1:
Figure S12B) has a mean over one standard deviation
above the general population (equivalent to an SRS score
of over 40). However, in the multiplex females (Figure 1B),
Table 3 Top five SNPs from tier 3 analysis: genome-wide


















Predicted . 97.0 <24.3 >88 ≤1×10−8 ≤0.05 97.0 <24.3 >88 ≤1×10−8
rs2387667 G/A 33.7 13.2 2.54 1.1×10−5 1.0 15.9 19.5 0.82 0.25
rs867764 A/G 33.7 13.2 2.54 1.1×10−5 1.0 23.2 23.5 0.99 0.92
rs10518301 A/G 25.0 47.0 0.53 1.4×10−5 1.0 40.1 41.1 0.98 0.79
rs9302760 A/G 75.0 53.0 1.42 1.4×10−5 1.0 60.4 56.4 1.07 0.31
rs4745013 G/A 36.1 58.9 0.61 1.7×10−5 1.0 49.8 47.8 1.04 0.62
Gockley et al. Molecular Autism  (2015) 6:25 Page 8 of 10
the mean SRS of the lower distribution females is the same
as the general population (SRS of 18).
Second, the simulation required a difference in mean
liability between males and females of 0.66 standard de-
viations (equivalent to an SRS of 12). However, the ob-
served SRS difference between males and females is
fourfold lower at 0.17 standard deviations (equivalent to
an SRS of 3). If we repeat the simulation using a sex
difference of 0.17 standard deviations, we observe lit-
tle distinction between the male and female distribu-
tions (Additional file 1: Figure S12C and S12D).
Therefore, while ascertainment bias may partially explain
the bimodal SRS in multiplex females, our analyses suggest
that it is not the complete explanation of this pheno-
menon. Similarly, the effect may be a consequence of
the sex of the parent rating the child for the SRS score.
However, we note that no such rater bias was detected
in epidemiologic sample of twins [24,34] and the bimodal
distribution has been observed for SRS scored by both
parents and teachers [23]. Finally, we considered whether
IQ could confound the SRS score; however, we observed
very weak correlation between the two measures with a
similar slope in males and females (Additional file 1: Figure
S13).
We next considered ‘biological’ explanations for the bi-
modal distribution. The ‘single locus’ observed may repre-
sent multiple rare risk factors rather than a single common
protective factor, for example, inherited large copy number
variation (CNV). The distribution may also be a conse-
quence of more complex interactions between multiple
factors mediating protection and risk. For example, a gen-
eral population twin study [24] observed that reciprocal so-
cial behavior in females, but not males, was influenced by
rearing factors that operated in the direction of promoting
social competency. Further exploration of the manner in
which inherited liability to ASD might capitalize upon,
or accentuate, developmental sexual dimorphisms in
gene expression, neuroanatomy, or behavior is warranted.
We note that a large family study [22] observed that a
high proportion of the unaffected sisters of ASD probands
manifested histories of early language delay with autistic
qualities of speech which later resolved. These observa-
tions offer potential clues to the manner in which FPE
might offset risk in the setting of autism susceptibility
early in life.
Microarray and exome sequencing studies have ob-
served an excess de novo mutation burden in ASD af-
fected females compared to ASD affected males [2,17-19];
however, a quantitative relationship was not observed be-
tween CNV trait burden and ASD symptom severity. This
underscores the possibility that FPE operates in a dichot-
omous manner, either offering complete protection from
ASD risk or being completely overwhelmed by an excess
of ASD risk.
Conclusions
In summary, the distribution of ASD severity in females
raised the possibility of an ASD protective effect in fe-
males mediated by a single genetic locus. If present, such
a locus is likely to have been missed by prior GWAS
analyses and would have great potential as a therapeutic
target. However, we performed a well-powered targeted
association study that found no evidence of such a genetic
locus. The FPE remains of great interest as a route to dis-
covering therapeutic targets; however, the mechanism of
this protection remains unknown.
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